New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2013
06:07 EDTCHL, AAPL, BRK.A, DISH, CLWR, WFC, USB, BATS, S, BAC, JPM, C, MS, GSOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: BATS Global Markets (BATS) said that a "system issue" allowed hundreds of thousands of transactions in a four-year period to be executed at prices that may have violated securities rules. SEC rules require orders to go to the best bid or offer in the market, the Wall Street Journal reports...Major banks pushed to complete an $8.5B legal settlement with federal regulators last weekend so they could book the deal's costs in their Q4 results and present a cleaner slate to investors in 2013, sources say, the Wall Street Journal reports...REUTERS: Sprint Nextel (S) is under no pressure to raise its $2B offer for Clearwire (CLWR) to beat a higher bid by Dish Network (DISH) as it holds several trump cards it can play to thwart its rival, sources say, Reuters reports...Apple (AAPL) CEO Tim Cook met with China Mobile (CHL) Chairman Xi Guohua today to discuss "matters of cooperation," a China Mobile spokesman said, raising hopes that a deal between the two may move forward, Reuters reports...BLOOMBERG: Berkshire Hathawayís (BRK.A) Warren Buffett, who oversees stakes in some of the largest U.S. banks, said the nationís lenders have rebuilt capital to the point where they no longer pose a threat to the economy, Bloomberg reports...The $500B market for leveraged loans, one of the last to depend on facsimile machines, is turning to computers to save time and money as stock, bond and commodities exchanges have done for years. More than four million faxes with information ranging from quarter-end payments to interest rates were received by loan custodians in 2012, Bloomberg reports.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 12, 2015
08:06 EDTALabCorp to offer new PD-L1 test for Bristol-Myers' Opdivo
Subscribe for More Information
05:17 EDTADasko announces FDA approval of Opdivo for patients with non-squamous NSCLC
Subscribe for More Information
October 9, 2015
18:31 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for OPDIVO
Subscribe for More Information
15:23 EDTADako announces FDA approval of new lung test for cancer patients
Subscribe for More Information
October 6, 2015
07:23 EDTAAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 5, 2015
05:29 EDTADako announces FDA approval of new companion diagnostic assay
Subscribe for More Information
October 2, 2015
15:57 EDTALabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
15:43 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for KEYTRUDA
Subscribe for More Information
15:25 EDTAAgilent's Dako confirms FDA approval of NSCLC diagnostic
Dako, an Agilent Technologies (A) company and a worldwide provider of cancer diagnostics, announced the FDA approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer, or NSCLC, is likely to respond to a new form of treatment. The approval of PD-L1 IHC 22C3 pharmDx strengthens Dako's portfolio of companion diagnostics and the company's leadership position in developing and commercializing companion diagnostic products. Dako developed PD-L1 IHC 22C3 pharmDx in partnership with Merck (MRK), maker of the anti-PD-1 therapy Keytruda. The FDA approved PD-L1 IHC 22C3 pharmDx for use in the United States. Dako hopes to gain regulatory approval for the new diagnostic in Canada, Europe and other jurisdictions next year.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use